BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Alliance - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hemophilia Alliance
X-ORIGINAL-URL:https://hemoalliance.org
X-WR-CALDESC:Events for Hemophilia Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241217T150000
DTEND;TZID=America/New_York:20241217T160000
DTSTAMP:20260531T121242
CREATED:20241126T182846Z
LAST-MODIFIED:20241126T182846Z
UID:69645-1734447600-1734451200@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A webinar from Pfizer on HYMPAVZI: An anti-tissue factor pathway inhibitor
DESCRIPTION:Date: Tuesday\, December 17\, 2024\nTime: 3:00pm – 4:00pm ET \n \n  \n  \n  \n  \n \nTOPIC: \nHYMPAVZI: An anti-tissue factor pathway inhibitor \nOBJECTIVE: \nTo educate attendees on the novel mechanism of action of HYMPAVZI\, the Ph3 clinical trial results and indicated dosage and administration. \nINTENDED AUDIENCE: \nHCP \nSPEAKER: \nDr. Jennifer Schumacher\, PhD\, Senior Medical Director\, Hemophilia \n \nJennifer Schumacher Sr. Medical Director has over 21 years of Medical Affairs and Biotech Industry experience. Currently\, a senior medical director in hemophilia\, Jennifer is the US medical lead for marstacimab. During her tenure at Pfizer\, she has held several positions beginning in US Medical Affairs in Oncology and transitioning to medical director in Rare Disease where she has lead the global medical team for transthyretin amyloid (ATTR) cardiomyopathy and served as publications lead. Jennifer joined the US hemophilia medical team in 2023. \nJennifer received her PhD in Pharmacology from the University of Minnesota\, Minneapolis\, USA and a B.S. in Biotechnology and Chemistry from St. Cloud State University\, St. Cloud\, USA. \nJennifer is based in Minneapolis\, Minnesota and enjoys spending time with her husband and two children. She loves reading\, cooking and the great outdoors\, snowmobiling in the winter and spending time with family and friends at their cabin in the summer.
URL:https://hemoalliance.org/alliance-events/a-webinar-from-pfizer-on-hympavzi-an-anti-tissue-factor-pathway-inhibitor/
CATEGORIES:Members Only
ATTACH;FMTTYPE=image/jpeg:https://hemoalliance.org/wp-content/uploads/2024/01/Pfizer.jpg
END:VEVENT
END:VCALENDAR